Johns Hopkins Medicine: CBD May Increase the Adverse Effects of THC in Edible Cannabis Products, Study Shows
February 14, 2023
February 14, 2023
BALTIMORE, Maryland, Feb. 14 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
Contrary to some common claims, a study led by Johns Hopkins Medicine researchers found that relatively high doses of cannabidiol (CBD) may increase the adverse effects of delta-9-tetrahydrocannabinol (THC), the main active ingredient in cannabis that can cause a mood alteration or a "high" sensation. The finding show that in edible cannabis products, CBD inhibits the metabol . . .
Contrary to some common claims, a study led by Johns Hopkins Medicine researchers found that relatively high doses of cannabidiol (CBD) may increase the adverse effects of delta-9-tetrahydrocannabinol (THC), the main active ingredient in cannabis that can cause a mood alteration or a "high" sensation. The finding show that in edible cannabis products, CBD inhibits the metabol . . .